Leaders from the VA and the ONC discussed how the future of U.S. healthcare will rely on both technology and creative problem-solving during a panel at DiMe’s Healthcare 2030 Summit.

From left to right: Soumi Saha, senior vice president of government affairs at Premier Inc.; Jennifer Goldsack, founder and CEO of the Digital Medicine Society Hallucinations are a frequent point of ...

AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention — are gaining traction in the healthcare world. The industry is under massive pressure ...

A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...

The U.S. Food & Drug Administration (FDA) recently removed its Risk Evaluation and Mitigation Strategies (REMS) designation from CAR T immunotherapies. REMS is occasionally applied to drugs with ...

During the MedCity INVEST Digital Health conference in Dallas, three executives shared what’s top of mind as they deploy AI in the healthcare workforce, including the need to build trust and improve ...

During a panel discussion at the MedCity INVEST Digital Health conference, investors shared what they're looking for from AI startups and what their red flags are.

Duke University Health System is deploying a mix of homegrown and purchased AI tools to ease clinicians’ administrative burden and improve patient care. Chief Nurse Executive Terry McDonnell ...

Harbor Health, a primary and specialty care clinic and insurance company, announced last week that it raised $130 million in funding. The financing will help expand its clinical reach in Texas and ...

Walgreens jumped on board the private equity rescue ship named Sycamore Partners earlier this year and late August the deal worth $10 billion was completed. While some say the sale to private equity ...